AngioDynamics Inc
ANGO10.560USD
+0.500+4.97%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
439.02MCap. mercado
PérdidaP/E TTM
Más Datos de AngioDynamics Inc Compañía
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Información de AngioDynamics Inc
Símbolo de cotizaciónANGO
Nombre de la empresaAngioDynamics Inc
Fecha de salida a bolsaMay 27, 2004
Director ejecutivoClemmer (James C)
Número de empleados675
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 27
Dirección14 Plaza Drive
CiudadLATHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal12110
Teléfono15187981215
Sitio Webhttps://www.angiodynamics.com/
Símbolo de cotizaciónANGO
Fecha de salida a bolsaMay 27, 2004
Director ejecutivoClemmer (James C)
Ejecutivos de AngioDynamics Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+890.00%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-36233.00%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Chad T. Campbell
Mr. Chad T. Campbell
Senior Vice President, General Manager - Global Oncology and Vascular Access
Senior Vice President, General Manager - Global Oncology and Vascular Access
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+890.00%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-36233.00%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
66.46M
87.78%
International
9.26M
12.22%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: mié., 4 de feb
Actualizado: mié., 4 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Divisadero Street Capital Management, LP
8.92%
BlackRock Institutional Trust Company, N.A.
7.04%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.91%
Otro
65.68%
Accionistas
Accionistas
Proporción
Divisadero Street Capital Management, LP
8.92%
BlackRock Institutional Trust Company, N.A.
7.04%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.91%
Otro
65.68%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
35.12%
Investment Advisor/Hedge Fund
34.15%
Hedge Fund
19.12%
Individual Investor
6.43%
Venture Capital
3.46%
Research Firm
2.32%
Pension Fund
1.68%
Bank and Trust
0.25%
Insurance Company
0.03%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
311
40.19M
106.71%
-10.46K
2025Q3
344
40.20M
109.06%
+1.51M
2025Q2
370
37.97M
110.38%
+1.85M
2025Q1
372
36.50M
106.59%
-6.63M
2024Q4
361
34.34M
98.76%
+1.35M
2024Q3
371
33.44M
109.60%
-216.03K
2024Q2
370
33.66M
118.59%
-3.23M
2024Q1
368
36.03M
115.74%
-10.10M
2023Q4
378
37.01M
114.23%
+355.36K
2023Q3
364
36.64M
109.90%
-219.51K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Divisadero Street Capital Management, LP
3.68M
8.92%
+282.69K
+8.33%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.90M
7.04%
-61.07K
-2.06%
Sep 30, 2025
Systematic Financial Management, L.P.
2.57M
6.24%
+60.60K
+2.41%
Sep 30, 2025
Point72 Asset Management, L.P.
2.56M
6.21%
+609.91K
+31.29%
Sep 30, 2025
The Vanguard Group, Inc.
2.36M
5.74%
-125.09K
-5.03%
Sep 30, 2025
Armistice Capital LLC
1.64M
3.97%
+108.19K
+7.08%
Sep 30, 2025
Segall Bryant & Hamill, LLC
1.32M
3.2%
-37.14K
-2.74%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.16M
2.8%
-16.92K
-1.44%
Sep 30, 2025
Clemmer James C
1.13M
2.74%
+10.00K
+0.89%
Oct 09, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
State Street SPDR S&P Health Care Equipment ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.63%
Vanguard US Multifactor ETF
0.15%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.06%
Avantis US Small Cap Equity ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
iShares Russell 2000 Value ETF
0.02%
Ver más
State Street SPDR S&P Health Care Equipment ETF
Proporción0.79%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.63%
Vanguard US Multifactor ETF
Proporción0.15%
iShares Micro-Cap ETF
Proporción0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.07%
Fidelity Enhanced Small Cap ETF
Proporción0.06%
Avantis US Small Cap Equity ETF
Proporción0.06%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.04%
iShares Russell 2000 Value ETF
Proporción0.02%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
